MedTrace Logo

COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking

NCT04408339 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-06-16

No results posted yet for this study

Summary

The COVIDHELP study will prospectively evaluate the yet unknown clinical course of the COVID-19 infection in cancer patients and document the impact of potential infrastructural limitations on cancer care of COVID-19 positive patients. All patients consenting will provide peripheral blood samples for prospective biobanking with the aim of investigating immune response and immunity against COVID-19.

Conditions

Interventions

OTHER

No Intervention

No Intervention

Sponsors & Collaborators

  • University Hopsital Schleswig Holstein Campus Lübeck

    collaborator OTHER

  • University Hospital Schleswig-Holstein

    collaborator OTHER

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Katja Weisel, MD · University Medical Center of Hamburg-Eppendorf

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-15
Primary Completion
2021-04-14
Completion
2022-04-14

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04408339 on ClinicalTrials.gov